The weekly litigation news digest is live. Subscribe now

IP Verse

Genentech competitive analysis

Loading summary...

Latest oppositions filed by Genentech

Explore patent oppositions filed by Genentech against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Nov 13, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP3177645
Subcutaneously Administered Bispecific Antibodies For Use In The Treatment Of CancerLINDHOFERNov 15, 2021

Latest patents of Genentech opposed by its competitors

Explore Genentech's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Nov 13, 2025
Patent NumberPublication DateTitleTotal Oppositions
EP2694072
Aug 7, 2024Combinations Of Akt Inhibitor Compounds And Abiraterone, And Methods Of Use1
EP4108259
Jan 3, 2024Process For Concentration Of Antibodies And Therapeutic Products Thereof1
EP3589661
Nov 1, 2023Adjuvant Treatment Of Her2-Positive Breast Cancer4
EP2784084
Oct 4, 2023Il-17 A/F Heterologous Polypeptides And Therapeutics Uses Thereof5
EP3597659
Mar 1, 2023Prevention Of Disulfide Bond Reduction During Recombinant Production Of Polypeptides9
EP3805248
Jan 18, 2023Process For Concentration Of Antibodies And Therapeutic Products Thereof2
EP3401335
Jun 30, 2021Composition Comprising Antibody That Binds To Domain Ii Of Her2 And Acidic Variants Thereof5
EP3337812
Apr 28, 2021Method For The Reduction Of Host Cell Proteins In Affinity Chromatography4
EP3570884
Sep 30, 2020Subcutaneous Her2 Antibody Formulations4
EP1543038
Aug 5, 2020Protein Purification1

Latest PTAB cases involving Genentech

Discover the latest PTAB cases involving Genentech, highlighting their recent legal challenges and patent disputes.

Last updated on: Nov 16, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Genentech

IPR2023-00052Oct 14, 2022DR REDDYS LABORATORIESGENENTECHFinal Written Decision
PGR2022-00023Feb 3, 2022DR REDDYS LABORATORIESGENENTECHFinal Written Decision
PGR2021-00039Jan 20, 2021MERCK SHARP & DOHMEGENENTECHInstitution Denied
PGR2021-00036Jan 7, 2021MERCK SHARP & DOHMEGENENTECHInstitution Denied
PGR2019-00043Apr 2, 2019ELI LILLYGENENTECHTerminated
PGR2019-00044Apr 1, 2019UCBGENENTECHTerminated
IPR2018-01019May 4, 2018CELLTRIONGENENTECHTerminated
IPR2018-00373Jan 5, 2018PFIZERGENENTECHInstitution Denied
IPR2018-00330Dec 18, 2017PFIZERGENENTECHInstitution Denied
IPR2018-00331Dec 18, 2017PFIZERGENENTECHInstitution Denied

Peer Comparison New

IP litigation analysis comparing Genentech with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 13, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
GENENTECH - 87 - 65
CELLTRION3 - 29 -
HOSPIRA - 387
PFIZER51944312